OXALIPLATINE HOSPIRA 5 mg/ml, concentrate for solution for infusion bottle, 40 ml
Active ingredients: Oxaliplatin
Commercialized according to BDPMDispensing in France: Prescription only
Concentrate for solution for infusionbottle, 40 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OXALIPLATINE HOSPIRA 5 mg/ml, solution à diluer pour perfusion
- Pharmaceutical form
- solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 40 ml avec Onco-Tain
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 May 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64101179CIP75744024CIP133400957440244Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| OXALIPLATINEsolution | 5 mg · 1 ml de solution à diluer pour perfusion | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.